This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Apr 10;41(11):1976-1978.

doi: 10.1200/JCO.22.02628. Epub 2023 Feb 27.

The National Clinical Trials Network: A Valuable and Undervalued Resource

Howard A Burris 3rd¹

Affiliations

PMID: 36848615
DOI: 10.1200/JCO.22.02628

Editorial

The National Clinical Trials Network: A Valuable and Undervalued Resource

Howard A Burris 3rd. J Clin Oncol. 2023.

. 2023 Apr 10;41(11):1976-1978.

doi: 10.1200/JCO.22.02628. Epub 2023 Feb 27.

Author

Howard A Burris 3rd¹

Affiliation

¹ Sarah Cannon Research Institute, Nashville, TN.

PMID: 36848615
DOI: 10.1200/JCO.22.02628

No abstract available

PubMed Disclaimer

Comment on

Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies.
Unger JM, LeBlanc M, George S, Wolmark N, Curran WJ Jr, O'Dwyer PJ, Schnall MD, Mannel RS, Mandrekar SJ, Gray RJ, Zhao F, Bah M, Vaidya R, Blanke CD. Unger JM, et al. J Clin Oncol. 2023 Apr 10;41(11):2020-2028. doi: 10.1200/JCO.22.01826. Epub 2022 Dec 8. J Clin Oncol. 2023. PMID: 36480773 Free PMC article.

Publication types

Actions
Actions